Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 425, doi. 10.1007/s40272-020-00405-3
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2020 AND VI 22 AND IP 4
Results: 10
1
2
Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 399, doi. 10.1007/s40272-020-00404-4
- By:
- Publication type:
- Article
3
Challenges and Opportunities in the Pharmacological Treatment of Acute Venous Thromboembolism in Children.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 385, doi. 10.1007/s40272-020-00403-5
- By:
- Publication type:
- Article
4
Target Drug Exposure Attainment in Children: How to Get from Better to Best.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 445, doi. 10.1007/s40272-020-00402-6
- By:
- Publication type:
- Article
5
Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 369, doi. 10.1007/s40272-020-00401-7
- By:
- Publication type:
- Article
6
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 433, doi. 10.1007/s40272-020-00400-8
- By:
- Publication type:
- Article
7
Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 417, doi. 10.1007/s40272-020-00399-y
- By:
- Publication type:
- Article
8
Eosinophilic Esophagitis: Update on Diagnosis and Treatment in Pediatric Patients.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 343, doi. 10.1007/s40272-020-00398-z
- By:
- Publication type:
- Article
9
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 357, doi. 10.1007/s40272-020-00397-0
- By:
- Publication type:
- Article
10
Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 4, p. 409, doi. 10.1007/s40272-020-00396-1
- By:
- Publication type:
- Article